Skip to content

Comparing the treatment outcome of two material as an Pulpotomy Agent for a year In Mature Permanent Molars With Symptomatic Irreversible Pulpitis

One-Year Comparative Evaluation Of Treatment Outcome Of Bioceramic Putty And An Injectable Bioceramic As Pulpotomy Agent In Mature Permanent Molars With Symptomatic Irreversible Pulpitis: A Double Blinded Randomized Clinical Study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112449
Enrollment
50
Registered
2026-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified

Interventions

Intervention1: Bioceramic Putty (cerafill Putty): It is pre-mixed, ready-to-use bioceramic material composed of tricalcium silicate, calcium aluminate, calcium oxide, zirconium oxide, iron oxide, sili

Sponsors

Dr Ayushi Chrungu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Systemically healthy patients (Category American Society of Anesthesiologists class 1) (ASA House of Delegates 2014) between age group of 18-40 years with maxillary or mandibular mature permanent carious teeth with radiographic and clinical evidence of symptomatic irreversible pulpitis will be included in the study. 2.Healthy gingiva with no swelling or sinus tract. 3.Active bleeding pulp tissue observed upon access opening and in all canals after full pulpotomy and hemostasis achieved within 5 min following full pulpotomy. 4.Radiographic evaluation showing a normal periapical index (PAI-1)24 5.A written informed consent will be taken from all the patients and only those patients ready to sign the consent form, willing to participate and come for multiple visits for follow up will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Teeth which are non-restorable, necrosed, badly broken or with developmental anomalies, heavy occlusal load, cracks or vertical root fractures will be excluded. 2. Teeth which are periodontally compromised, present with localized gum swelling or showing evidence of sinus tracts, pus discharge and weeping canals will be excluded. 3. Radiographic evidence of inter radicular lesions, internal external root resorption, open apex or pulp stone in pulp chamber will be excluded from the study. 4. Pregnant and lactating women will be excluded. 5. Intraoperative Evaluation If the remaining pulpal tissue displayed a pale yellow, dark brown coloration, it will be excluded.

Design outcomes

Primary

MeasureTime frame
1. To evaluate the treatment outcome of Bioceramic Putty clinically and radiographically as a pulpotomy agent in mature permanent molars with symptomatic irreversible pulpitis at base-line 24hours,2weeks ,6months and 1 year period 2.To evaluate the treatment outcome of Injectable Bioceramic clinically and radiographically as a pulpotomy agent in mature permanent molars with symptomatic irreversible pulpitis at base-line 24hours,2weeks ,6months and 1 year period. 3.To compare the treatment outcome of Bioceramic Putty with Injectable Bioceramic clinically and radiographically as pulpotomy agent in mature permanent molars with symptomatic irre-versible pulpitis at baseline 24hours,2weeks ,6months and 1 year period Timepoint: Baseline 24hours,2weeks ,6months and 1 year period

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Ajay Singh Rao

KM Shah Dental College And Hospital

drajayinendo@gmail.com8385017307

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026